iShares Genomics Immunology and Healthcare ETF (IDNA): ETF
ETF traded on ARCX under symbol IDNA. Quoted in usd.
iShares Genomics Immunology and Healthcare ETF
+2.15%$42.31
ARCX:IDNAEquity
AUM $346.34M·YTD --·Yield --
ARCX:IDNA$42.31+2.15%AUM $346.34MAbout IDNA
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
Largest holdings
- MRNA MODERNA14.92%
- GMAB.CO GENMAB5.94%
- TWST TWIST BIOSCIENCE4.86%
- BAYN.DE BAYER AG4.13%
- REGN REGENERON PHARMACEUTICALS3.96%
- 4502.T TAKEDA PHARMACEUTICAL3.75%
- EXEL EXELIXIS INC3.67%
- RVMD REVOLUTION MEDICINES3.59%
- VRTX VERTEX PHARMACEUTICALS3.41%
- MRK MERCK & CO INC3.38%
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$110,297
Total Return
+$40,297
(+57.6%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$346.34M
NAV$42.24
Premium/Discount+0.17%
Expense Ratio0.47%
Market Cap--
Shares Outstanding--
Inception DateJun. 11, 2019
Fund Details
IssuerIShares
Asset ClassEquity
Beta--
SectorFinancial Services
DomicileUS
52-Week Range
$24.29$44.15
Current: $42.31
Volume
Volume224.66K
Avg Volume124.61K
Vol/Avg1.80x
30d
171.41K
60d
177.15K
90d
159.37K
Comparable ETFs